Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-DM1 with Docetaxel and Pertuzumab in Advanced Breast Cancer
NCT00934856Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2009
- Primary completion
- Oct 2013
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of trastuzumab emtansine in breast cancer, sponsored by Roche. Started Jul 2009; status: completed.
02
Drugs
trastuzumab emtansine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00934856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00934856.